A Study Comparing Amounts of 2 Different Forms of Tafamidis (PF-6291826) in the Blood
Clinical trial NCT03266705 · COMPLETED
Trial details
- NCT number
- NCT03266705
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2018-02-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.